Abingdon Health is delighted to announce the appointment of Olly Gardner as Chief Operating Officer. Olly has a wealth of leadership experience from...
Abingdon Health is delighted to announce the UK-RTC has reached design freeze for the AbC-19TM lateral flow test for IgG antibodies to the...
Professor Mike Holmes appointed as a medical advisor to support Abingdon Health’s work on developing SARS-CoV-2 rapid tests.
Abingdon Health appoints Lyn Rees as non-executive director and board member.
Investment in state-of-the-art automation cements Abingdon Health’s position as a leading global rapid test manufacturer
Professor Lawrence S. Young appointed as a scientific advisor to support Abingdon Health’s work on developing SARS-CoV-2 rapid tests.
Concepta PLC to use Abingdon Health‘s lateral flow m-Health technology in the fertility tracking and pregnancy testing market
Abingdon Health announces expansion via the acquisition of Concepta plc’s Doncaster facility
Abingdon Health announces membership in UK Rapid Test Consortium to deliver a new COVID-19 antibody rapid test
Abingdon Health and DCN Diagnostics have announced a commercial partnership to provide Abingdon Health’s proprietary AppDx Smartphone m-Health technology to DCN Diagnostics’ customer...
UK lateral flow rapid test manufacturer, Abingdon Health, confirms expansion at its York site